Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: Implications for fusion-inducing conformational changes

被引:76
作者
de Rosny, E
Vassell, R
Jiang, S
Kunert, R
Weiss, CD
机构
[1] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
[2] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA
[3] Univ Nat Resources & Appl Life Sci Vienna, Inst Appl Microbiol, A-1180 Vienna, Austria
关键词
D O I
10.1128/JVI.78.5.2627-2631.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We investigated how the broadly neutralizing monoclonal antibody 2F5 affects the human immunodeficiency virus type 1 envelope glycoprotein as it undergoes receptor-induced conformational changes and show that 2F5 binds both native and fusion-intermediate conformations, suggesting inhibition of a late step in virus entry. We also demonstrate conformational changes in the C heptad of gp41.
引用
收藏
页码:2627 / 2631
页数:5
相关论文
共 42 条
[1]   Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion [J].
Barbato, G ;
Bianchi, E ;
Ingallinella, P ;
Hurni, WH ;
Miller, MD ;
Cilibertol, G ;
Cortese, R ;
Bazzo, R ;
Shiver, JW ;
Pessi, A .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 330 (05) :1101-1115
[2]   A monomeric 310-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41 [J].
Biron, Z ;
Khare, S ;
Samson, AO ;
Hayek, Y ;
Naider, F ;
Anglister, J .
BIOCHEMISTRY, 2002, 41 (42) :12687-12696
[3]   A SPRING-LOADED MECHANISM FOR THE CONFORMATIONAL CHANGE OF INFLUENZA HEMAGGLUTININ [J].
CARR, CM ;
KIM, PS .
CELL, 1993, 73 (04) :823-832
[4]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[5]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[6]   Peptides corresponding to the heptad repeat motifs in the transmembrane protein (gp41) of human immunodeficiency virus type 1 elicit antibodies to receptor-activated conformations of the envelope glycoprotein [J].
De Rosny, E ;
Vassell, R ;
Wingfield, PT ;
Wild, CT ;
Weiss, CD .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8859-8863
[7]   NATIVE OLIGOMERIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN ELICITS DIVERSE MONOCLONAL-ANTIBODY REACTIVITIES [J].
EARL, PL ;
BRODER, CC ;
LONG, D ;
LEE, SA ;
PETERSON, J ;
CHAKRABARTI, S ;
DOMS, RW ;
MOSS, B .
JOURNAL OF VIROLOGY, 1994, 68 (05) :3015-3026
[8]   Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein [J].
Earl, PL ;
Broder, CC ;
Doms, RW ;
Moss, B .
JOURNAL OF VIROLOGY, 1997, 71 (04) :2674-2684
[9]   Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion [J].
Finnegan, CM ;
Berg, W ;
Lewis, GK ;
DeVico, AL .
JOURNAL OF VIROLOGY, 2002, 76 (23) :12123-12134
[10]   Genetic evidence that interhelical packing interactions in the gp41 core are critical for transition of the human immunodeficiency virus type 1 envelope glycoprotein to the fusion-active state [J].
Follis, KE ;
Larson, SJ ;
Lu, M ;
Nunberg, JH .
JOURNAL OF VIROLOGY, 2002, 76 (14) :7356-7362